Author Topic: Covid Culture (was Outbreak Culture)  (Read 106283 times)

0 Members and 6 Guests are viewing this topic.

Offline waldo

  • Full Member
  • ***
  • Posts: 8715
Re: Covid Culture (was Outbreak Culture)
« Reply #2880 on: February 20, 2021, 12:50:51 am »
Yet Manitoba has signed a deal for 20 million doses of their vaccine.
Yes, our premier just gave away 7M dollars.

If mRNA is the future of vaccines, I'm surprised the federal government has shown such little interest in Providence. I hope that changes.
Oct 2020 presser from Providence highlighting Liberal government support... phase 1 trial just started a few weeks back now - last week in January.



as for the earlier reference to Manitoba/Conservative Premier Pallister's lame-assed move, Pallister had to 'save face' after he falsely claimed the federal government was preventing the provinces/Manitoba from purchasing vaccines directly. So Pallister sure showed em, hey: that potential Providence vaccine, if all trial requirements prove successful... skepticism abounds that Providence could even have a vaccine in production by year-end!

naturally O'Foole/CPC were loudly singing the praises for Manitoba Premier Pallister's push to directly procure a vaccine... of course a most obliging media is regularly carrying water for the O'Foole/CPC misinformation campaign claiming a, 'Trudeau vaccine bungle'. As it's just now been revealed, Key components of Pallister's 'made-in-Canada' vaccine sourced from U.S. and Switzerland

so, for Manitoban's, that's a $7.2-million, non-refundable down payment on a $36-million deal that presumes to deliver 2 million doses of a vaccine by year-end... from a company just now entering into a Phase 1 clinical trial.

Quote
Some experts believe getting that first shipment of doses to market before the end of the year would be a stretch, if not downright impossible.

"The best case scenario? Probably early in the new year," said Prof. Mahesh Nagarajan, who specializes in supply chain management at the UBC Sauder School of Business. University of Ottawa School of Epidemiology and Public Health Prof. Amir Attaran is more skeptical.

"Providence delivering a vaccine by Dec. 31 is so improbable as to belong in the realm of fantasy in my opinion," said Attaran.

He doubts Providence will be able to enrol sufficient participants in its Phase 2 and Phase 3 trials, which have yet to be approved by Health Canada.

He also questions the company's ability to compete with Pfizer, the maker of one of the two approved vaccines in Canada.

"How is Providence, which is operating out of a minuscule office in Calgary, going to go up against that?" said Attaran.